Plasmid expression cassette design must include a thoughtful analysis of potentially every nucleotide comprising a covalently closed circular or end-protected linear DNA. This review will discuss recent studies in unraveling the mechanisms of postdelivery gene silencing, codon optimization and promoter identification. The recent discovery of potent RNA interference (RNAi) mechanisms for sequence-specific gene silencing has also invoked a great deal of interest in development of expression cassettes that can produce double-stranded RNA molecules for RNAi. Expression cassettes based on both RNA polymerase II and polymerase III transcription units that generate double-stranded RNA molecules for RNAi will also be discussed. Gene Therapy (2005) Whether a mammalian cell expression cassette is produced by bacterial amplification, minicircle recombination, or by purely synthetic means, the primary DNA
In brief Progress
Bacterial DNA sequences silence covalently attached mammalian transcription units. Codon optimization and codon pairing will affect transcriptional and translational efficiency. Databases aid promoter identification, transcriptional sequence element content and functional characterization. RNA polymerase III expression cassettes can generate siRNA-like molecules to accomplish gene silencing through RNA interference. Incorporation of inducible regulatory elements in Pol III promoter cassettes can provide control of RNAimediated gene silencing. Endogenous precursor microRNA transcript structures serve as templates in designing Pol II expression cassettes for RNA interference.
Prospects
Mining of databases linking sequence and functional information will play an increasingly significant role in optimization of mammalian expression cassette design. Expression cassettes will consider codon usage, codon pairing, CpG motifs and destabilizing elements such as A-U-rich elements. Functional databases of promoter activity in terms of strength and constitutive, environmental or tissuespecificity will become available for promoter selection. Determination of near-consensus splice sites in cDNA, their removal by silent codon mutagenesis and empirical testing may reveal additional gene expression enhancements or the absence of unwanted aberrant transcripts. Empirical data on effective sequences for RNA interference will help improve predictive algorithms for the design of siRNA and shRNA molecules. Additional data on miRNA biogenesis, processing and targets, will aid the design of Pol II-driven RNAi expression cassettes. Potential therapeutic applications remain dependent on the ability to deliver these macromolecules to the appropriate tissue and cell types.
sequence must be considered and will ultimately affect its transcriptional and translational efficiency. [1] [2] [3] [4] For the case of bacterially produced plasmids, the absolute requirement for a prokaryotic origin of replication and an antibiotic resistance gene driven by a bacterial promoter introduces prokaryotic sequences that often contain unmethylated CpG motifs. This is due to the fact that the frequency of CpG sequences in Escherichia coli bacterial genomes are seven-fold higher than for vertebrate genomes, with unmethylated CpG sequences in vertebrate genomes occurring at approximately 3% the frequency of E. coli. 5 These sequences may induce inflammatory cytokines and/or result in silencing of the colinear mammalian transcription unit. To examine the influence of bacterial sequences on mammalian transcription units, a recent study compared in vivo expression from covalently closed circular plasmid DNA (ccDNA) to expression from a mixture of two fragments derived from the same plasmid by restriction digestion. After hydrodynamic injection into mice, serum analysis demonstrated that by disconnecting the bacterial sequences from the expression unit 10-to 100-fold higher amounts of human a-1 antitrypsin or factor IX were produced compared to the original ccDNA. 5 Using a single enzyme to linearize the ccDNA within the bacterial sequence did not produce a similar enhancement, suggesting that the bacterial sequences acted in cis to silence expression.
In a corroborating study, the effect of CpG content on transgene silencing in transgenic blastocysts, embryos and mice was also recently examined. 6 The mammalian translation elongation factor 1 promoter (CpG content of 6.2%) was coupled to LacZ reporter gene constructs. The individual LacZ genes were engineered to contain high (9.2%), normal (1.6%) or null (o0.1%) CpG content. The transgenic model allowed analysis of expression during gametogenesis and the blastocyst stage, when the genome is hypomethylated, to embryonic day 9.5 and beyond, when methylation of the genome takes place. The model exhibited strong expression of LacZ in blastocysts for all transgene constructs, but expression only of the null CpG transgene at embryonic day 9.5 and beyond. The CpG sequences in the LacZ transcribed region were shown to be methylated as was the CpG island in the promoter. The authors propose a cis-acting mode of action, whereby methylation of the transgene CpG sequences leads to a structural change in the chromatin, or a spread of de novo methylation due to properties of the methylation complex itself, either of which result in the aberrant methylation of the elongation factor 1 promoter CpG island and gene silencing. This proposed mechanism of action is supported by the studies of Chen et al 7 though these authors additionally suggest that cytokine activation by the CpG sequences may be involved in the methylation response itself.
The removal of bacterial sequences from the transgene expression unit for human factor IX and a1-antitrypsin resulted in highly significant increases in protein level and duration of expression in another study by Chen et al. 7 In this work, minicircle vectors devoid of bacterial sequences were prepared using a unidirectional fC31 phage recombinase system. When the minicircles were hydrodynamically injected, 45-and 560-fold higher factor IX and a1-antitrypsin levels were achieved, respectively, at 3 weeks post-transfection compared to the bacterial plasmids. Southern blot analysis showed roughly equivalent copy number for minicircle vector versus ccDNA, suggesting that the serum level of a1-antitrypsin was not due to delivery differences in the amount of each vector. The Southern blot study further established that the minicircle remained as an intact episomal circle, as did the ccDNA, which suggested that an immune response against the cell harboring the vector DNA was not involved in the expression differences between ccDNA and minicircles.
While the silencing of transgenes due to the presence of CpG sequences is a compelling reason to remove them from an expression cassette, their adjuvant-like properties in DNA vaccine vectors may offer an advantage that overrides the short-term expression of the antigen transgene. Most expression vectors containing CpG sequences can express high levels of protein for at least 24-48 h, which may be enough antigenic stimulation for an immune response to take place. Cellular immune responses in particular may be elicited since these sequences induce Th1-like cytokine profiles. In consideration of the results of Chevalier-Mariette et al, 6 whereby methylation of CpG sequences in the bacterial transgene lead to aberrant methylation of the mammalian promoter CpG island and gene silencing, future DNA vaccine design may want to empirically explore the inclusion of additional CpG sequences within a mammalian promoter CpG island, and their complete elimination in the coding sequence of the mammalian transcription unit and expression cassette. As suggested by the studies just discussed, such an approach may optimize both the adjuvanticity of the vector while prolonging the expression of the antigen transgene.
The overall lack of immunogenicity of vertebrate DNA relative to bacterial DNA remains uncertain, although suppression of CpG and methylation of 70-80% of the cytosines in CpG in vertebrate genomes clearly play a role. 5 CpG sequence context, in particular cytosine residues upstream and guanosine residues downstream, strongly inhibit CpG effects, but other sequences, especially guanosine-rich motifs may be more effective. 5 Until a better understanding of these inhibitory sequences and their ability to quench CpG effects in bacterial sequences are empirically tested, minicircle derived vectors or purely synthetic DNA are the best alternatives for all vertebrate DNA vectors.
Codon optimization and codon pairing will affect transcriptional and translational efficiency
Removing bacterial sequences such as CpG's from expression vectors by alternative codon usage has been shown to dramatically increase amount and duration of gene expression through the avoidance of gene silencing mechanisms. It is also known that rare codon usage and a lesser-known phenomenon caused by over-or underrepresented codon pairing (codon availability which influences faster or slower translation) may be as detrimental to gene expression via different mechanisms than transcriptional silencing. Rare codon usage is postulated to result in translational stall due to tRNA unavailability (low concentration), while over-represented codon pairs may stall because of ribosome pausing. Conversely, under-represented codon pairs may enhance translational efficiency of a transcript, and ultimately effect large increases in protein production level by the cell. Two recent studies exemplify these phenomena, and through codon analysis and optimization, correct them. Trinh et al 8 demonstrated a codon pairing effect when trying to express a bispecifictetravalent antibody in murine myeloma cells. The heavy chain fusion construct they engineered contained an identical nucleotide sequence to encode the poly-glycineserine linker used to separate the C H 3 domain (constant region 3, Ig heavy chain) and single chain Fv (functional variable domain), and to separate the V H (variable Ig region on heavy chain) and V L (variable region on Ig light chain) domains within the Fv. The authors were unable to develop stable transfectants with this construct whether or not different regulatory sequences or different host cell lines were used. Through sequence analysis for codon usage, rare codon usage was not evident but the authors correctly identified a codon pair that was significantly over-represented in the linker sequence. Silent codon mutagenesis of a single nucleotide changed one codon of a glycine-glycine codon pair and converted the codon pair from 'slow' to 'fast' as measured by its w 2 value. (The w 2 value is a statistical representation of either highly over-or under-represented codon pairs and is obtained from an available database derived from the analysis of 3721 (61 2 ) codon-pairs from 271 mammalian genes. 9 ) When the expression cassette included the mutagenized codon in the linker sequence, the construct yielded stable transfectants with 30-fold higher protein expression (measured by transient transfection assays). Further experiments showed no differences in mRNA level or stability when compared to the original plasmid, demonstrating that the successful function of the expression cassette occurred at the level of translation predicted by the codon-pair nonrandom utilization hypothesis.
It is known from the expression of mammalianderived gene sequences in bacteria that silent codon mutagenesis of mammalian gene sequences to codons that are preferred in bacteria significantly enhances translation and protein production by the bacteria. The same is true for the expression of a gene derived from a virus or bacteria, which may be used as the antigen transcription unit in a DNA-based vaccine. Gao et al 10 reported the development of a new algorithm, UpGene, for codon optimization, which they used to optimize expression of simian immunodeficiency virus (SIV)-derived genes for high-level eukaryotic expression. HIV and SIV gene sequences contain many rare codons when compared to highly expressed human genes. These viral genes also contain sequences for export of unspliced viral RNA, which destabilize mRNA by unknown mechanisms when expressed out of their normal viral context in mammalian expression systems. These destabilizing sequences have been identified as AU-rich elements (ARE). The authors additionally developed the algorithm to identify ARE elements and modify codon usage to eliminate them. Along with rare codon and ARE elimination, the algorithm was used for optimization of the Kozak consensus sequence at the transcriptional start site of the genes they went on to test. In their studies, pcDNA3-based expression cassettes were engineered with the optimized (eukaryotic codon usage, ARE elimination and Kozak consensus transcriptional start site) or wild-type genes for SIV-derived gag and env genes. The optimized or wild-type gene expression plasmids, as well as recombinant adenovirus derived from each, were transfected into HEK293 cells for comparative analysis. Western blot technique was used to show high expression (though not quantified) of the optimized constructs compared with undetectable expression of the wild-type genes in all cases. The 'UpGene'-algorithm is the first codon optimization software made publically available at http://www. vectorcore.pitt.edu/upgene.html.
Another important application of silent codon mutagenesis may be in the removal of near-consensus splice sites (NCSS) from cDNA. The cDNA version of a gene is more commonly used in an expression cassette primarily because of its smaller size due to lack of intronic sequences. cDNA's do however commonly contain intronic consensus and near-consensus splice donor, acceptor and branching sequences, which are recognized by splicing complexes (spliceosomes). Examples of therapeutically important cDNA's containing NCSS are shown in Table 1 with weighted values indicative of the degree of similarity to the consensus sequence (1.0 ¼ perfect consensus match). Spliceosomes assembling on these sequences may be destabilizing to the cognate RNA resulting in their elimination and/or production of aberrant (not full length) mRNA and protein. Truncated proteins may additionally have the potential of being immunogenic. Preliminary data generated by these authors as well as published studies by others suggest that the presence of NCSS do, on occasion, severely affect expression level. Determining the presence of these sequences within a coding region Recent progress in transgene and RNAi expression cassettes CR Ill and HC Chiou and their elimination could be an important feature in achieving optimal expression from a cDNA. Table 1 would suggest that though these therapeutically important cDNA's contain many NCSS, their presence may not be a priori inhibitory to expression since apparently viable commercial processes exist. Early studies did however demonstrate that correction of near-consensus cryptic splice site prevented aberrant splicing and enabled the production of biologically active proteins. Therefore, while the process of NCSS identification and correction requires reasonable effort and complete synthesis of new coding regions, the benefits may be unforeseen and only realized through empirical testing.
Databases aid promoter identification, transcriptional sequence element content and functional characterization
As promoters are an absolute requirement for transgene expression in any mammalian expression cassette, identification of new promoters and their functional analysis remains a keen interest. The development of a database of transcriptional start sites (available at http://dbtss.hgc.jp/) with analysis of the immediate upstream sequences, when aligned against genomic DNA, was previously utilized to identify promoters. More recently, a study by Trinklein et al 11 used a similar approach but combined it with a reporter gene transfection assay. In their study the authors first aligned 10 276 full-length cDNA's from the Mammalian Gene Collection database (available at http://mgc.nci.nih.gov/index_html) to a draft sequence of the human genome using the BLAT algorithm (available at http://genome.ucsc.edu/cgi-bin/ hgBlat?command ¼ start). The genomic sequence 550 base pairs upstream and 50 bp downstream of the transcriptional start site was determined and 152 random fragments (out of 10 276) were combined with a luciferase gene and transfected into four human cell lines; embryonic kidney (HEK293), fibrosarcoma (1080), cervical carcinoma (HeLa) and hepatic carcinoma (HepG2). The method was highly effective for promoter detection in that 91% of the expression plasmids expressed luciferase in at least one cell line and 89% in at least two of the cell lines. The authors cleverly plotted the number of promoters with a similar coefficient of variance (CV, standard deviation divided by the mean, where activity of each promoter in each cell line was averaged) and produced a reasonably normal distribution. The promoter groups with low CVs were hypothesized to be constitutive whereas those with high CVs were more likely cell-type specific. Another data mining study of promoter regions was recently published by Marino-Ramirez et al, 12 which looked at over-represented strings of eight nucleotides (words) determined statistically by their z-score. (The z-score is a measure of the distance in standard deviations of a sample from the mean). The authors used the algorithm Spidey, which aligns cDNA to genomic DNA (available at http:/ /www.ncbi.nlm.nih.gov/IEB/Research? Ostell/Spidey/) to determine sequences À2000 to +1000 bp relative to the transcriptional start sites in the putative promoter regions (PPRs) of 5700 full-length cDNAs. The analysis resulted in 4737 PPRs from the human genome, where 76% had CpG islands, 28% had TATA boxes, 60% had CAAT boxes and 88.6% had GC boxes. The analysis showed the most over-represented eight-letter word (highest z-score) was gggcgggg, which is the sequence recognized by transcription factor Sp1. Additionally, 12 of the 16 most over-represented eight letter words had entries in the transcription factor database TRANSFAC (available at http://www.gene-regulation.com). The percentage of CpG islands in this promoter region study was significantly higher than previously recognized. The PPRs database is available through the National Center for Biotechnology Information, (ftp://ftp.ncbi.nlm.nih.gov/pub/ marino/published/hs_promoters/fasta/with permission).
Testing all these promoters functionally in terms of strength and specificity will be crucial. Assessment of promoters with cotransfected reporter plasmids for normalizing differences between promoters are subject to artifacts associated with copy number variation. Novel expression tools such as a dual luciferase reporter plasmid may be useful. In a recently reported new expression cassette design, the multiple cloning site for a test promoter driving firefly luciferase is in the opposite orientation of a CMV-promoter driving Renilla luciferase. 13 The design is very useful for promoter strength comparability, and eliminates copy number variability as well as transcriptional read-through by the opposing orientation of the two luciferase genes.
While nuclear expression plasmids based on RNA polymerase II (Pol II)-type promoters are most common, in a recent study, Finn et al 14 demonstrated an improved expression cassette design for cytoplasmic expression of a transgene. The cassette employed a nuclear promoter upstream of a T7 bacteriophage promoter driving RNA polymerase, and combined the RNA polymerase gene and transgene of interest in the same plasmid. The utilization of an internal ribosome entry site for the T7-driven cytoplasmic-expressed reporter gene was increased in an autocatalytic manner 20-fold higher than CMV-driven nuclear expression of the reporter gene. The autocatalytic nature of this expression system achieves a high level expression of transgene yet may bypass the requirement of high copy number plasmid delivery to the nucleus. The system still requires delivery to the nucleus to generate catalytic levels of the cytoplasmic-acting viral polymerase, which may itself be a rather immunogenic protein, as may the bacteriophage promoter. This will need to be determined by further in vivo testing.
It is clear that those in the gene therapy field will benefit from specialized databases arising from deposition of vertebrate genomes as well as new algorithms for mining theses sequences. The creation and deposition of functional sequence information and technology for rapid synthesis of kilobase stretches of DNA will greatly accelerate expression vector optimization and therefore their functional characterization.
RNA polymerase III expression cassettes can generate siRNA-like molecules to accomplish gene silencing through RNA interference
The recent discovery of powerful, endogenous mechanisms of gene silencing by RNA interference (RNAi) in plants, invertebrates and mammalian cells (reviewed in Hannon 15 and Caplen 16 ) has sparked keen interest in the potential of RNAi-based therapeutics. 17, 18 However, the primary activator of RNAi in plant and invertebrate cells, Recent progress in transgene and RNAi expression cassettes CR Ill and HC Chiou long double-stranded RNA (dsRNA), triggers interferonrelated nonspecific and general host shutdown mechanisms in mammalian cells. To avoid such nonspecific effects, it was found that dsRNA molecules of less than 30 nucleotides (nt) in length could achieve RNAimediated gene-specific inhibition without triggering interferon responses. While the administration of short interfering RNA duplexes (siRNA) may be appropriate for certain therapeutic applications, expressible plasmids that could generate short dsRNA molecules would offer the potential for amplification of the active molecule in the cell, longer persistence and, possibly, control of where and when the therapeutic is expressed. Potential therapeutic applications, however, remain dependent on the ability to deliver these macromolecules to the appropriate tissue and cell types. Though steady progress has been made in development of various nonviral, chemical or physical methods of gene delivery, 19, 20 none yet exhibit sufficient efficacy for direct clinical applications. Progress in the therapeutic application of gene silencing mechanisms will require continued improvement of in vivo delivery methods.
To express short RNA molecules, RNA polymerase III (Pol III) promoters of the Type 3 group are the first and most obvious choice. Pol III genes encode structural or catalytic RNAs of less than 400 nt. A short run of about five T residues serves as the termination signal. Thus Pol III transcripts normally have 3-4 U residues at the 3 0 end (for a review see Schramm and Hernandez 21 ). A flurry of papers in 2002 from five different groups [22] [23] [24] [25] [26] established that short hairpin RNA (shRNA) molecules expressed from U6 or H1 Type 3 Pol III promoters could mediate sequence-specific RNAi-based gene inhibition. All of the groups designed expression units where the RNA sequence expressed from the Pol III promoters contained an inverted repeat of 19-29 nt separated by a short spacer sequence (See Figure 1a) . Upon expression the inverted repeat forms a double-stranded stem structure with the spacer forming a loop. The first transcribed nucleotide position (+1) of the U6 and H1 promoters is part of the promoter element. Thus, the short RNAs expressed from the U6 promoter must begin with guanosine, while those expressed from the H1 promoter must begin with adenosine. To match the prototype model for siRNA molecules, some groups designed the hairpins to contain two uridines at the 5 0 end of the loop sequence. Though various lengths for the double-stranded stems, as well as length and sequence of the loops were examined, no consensus emerged as to which hairpin configuration generated the most active RNAi molecules.
Concurrent with reports on expression of hairpin RNAs to elicit RNAi gene inhibition, two groups also reported on Pol III expression cassettes utilizing tandem transcription units (see Figure 1b) to individually express the two complementary strands of a duplex siRNA molecule. 27, 28 Upon expression in the cell, the complementary strands anneal to form siRNA molecules with overhanging 3 0 ends. Probably due to the lower efficiency of requiring two separate RNA strands to find and anneal to each other, these dual expression cassette designs have been found to be generally less effective than hairpin designs, though they can achieve substantial gene inhibition.
As Type 3 Pol III transcription unit structure is very compact, requiring minimal regulatory sequence elements, several groups have realized the possibility of designing convergent transcription strategies (see Figure 1c) to express siRNA molecules. 29, 30 In the more elegant approach of Kaykas and Moon, 30 a sequence of 19 nt that match the intended RNAi target was immediately flanked by converging U6 and H1 Pol III promoters. Both promoters were modified in order to incorporate Pol III termination signals, comprising 5T residues, into the À5 to À1 positions. Thus, the converging promoters directed expression of two 21-25 nt RNAs containing a 19 residue complementary sequence and four U residues at the 3 0 end. After expression the complementary RNA transcripts anneal to form siRNA molecules with 3 0 overhangs. A potential advantage of this convergent transcription strategy is that when two different promoters are used, such as the U6 and H1 promoters, the plasmid does not contain any repeat sequences. In the case of hairpin expression units and tandem promoter constructs, the required repeat elements in the plasmid can lead to sequencing difficulties and instability in bacterial hosts. However, no direct comparisons have yet been made to determine if these convergent transcription expression cassettes are as effective as hairpin designs for RNAi. 
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Incorporation of inducible regulatory elements in Pol III promoter cassettes can provide control of RNAi-mediated gene silencing
The tremendous interest in both therapeutic and research-related applications of RNAi has spurred development of enhancements to Pol III promoter function. Earlier work had described interactions between Pol III promoters and upstream RNA polymerase II (Pol II)-type enhancers. Thus Xia et al 31 successfully employed a CMV enhancer-U6 promoter chimera to increase the production of shRNA from their expression cassette compared to a U6 promoter-only construct.
To achieve greater control over shRNA expression, several groups have designed U6 or H1 promoter expression cassettes to incorporate elements responsive to various small molecules such as tetracycline or doxycycline [32] [33] [34] and ecdysone. 35 To date, these inducible systems require expression of additional repressor or activator proteins. It remains to be seen if other Pol IIbased inducible or regulatable elements can be incorporated into Pol III promoter systems.
Endogenous precursor microRNA transcript structures serve as templates in designing Pol II expression cassettes for RNA interference While Pol II promoters have been extensively studied, modified, enhanced and chimerized, much less experimentation has been done with Pol III promoters. The ability to generate RNAi molecules from Pol II transcription units would take advantage of the flexibility and variety of Pol II promoter designs. However, unlike the simple structure of Pol III genes, the structural requirements of Pol II-transcribed RNAs include elements, such as 5 0 end caps and 3 0 polyA tails, which must be removed for RNAi activity. The discovery of endogenous microRNAs (miRNA) has created an avenue for the use of Pol II transcription units for expression of RNAi molecules.
MicroRNAs are single-stranded B22 nt regulatory RNAs derived from longer RNA transcripts. Though the specific function of many miRNAs are not known, as a class they are involved in regulation of cellular processes by means of post-transcriptional gene-silencing. The size and function of miRNAs point to their similarity to siRNA molecules. Indeed, a substantial body of work has now established that miRNAs and siRNAs utilize common molecular pathways to achieve sequence-specific gene inhibition. 36 More importantly for the design of RNAi expression cassettes, some, if not all, miRNAs arise from RNA transcripts generated from Pol II promoters. 37, 38 The small miRNA molecules are generated from discrete hairpin structures of B60-90 nt that are cropped out of longer precursor RNA transcripts. Known as precursor miRNA (pre-miRNA), these hairpins are exported from nucleus to cytoplasm and further processed by enzymatic cleavage of the loop structure to ultimately give rise to the B22 nt miRNA molecule responsible for gene silencing (Figure 2) .
When embedded into Pol II mRNA transcripts of irrelevant sequence, pre-miRNA sequences are readily excised and specifically inhibit expression of mRNAs Figure 2 MicroRNA biogenesis from Pol II transcription units. miRNAs (shown in bold) are embedded within the 3 0 arms of hairpin structures contained within Pol II generated transcripts called primary miRNA or pri-miRNA transcripts. Short hairpin structures, pre-miRNA, are produced through cleavage from the pri-miRNA by the RNase III enzyme Drosha. After export into the cytoplasm, the pre-miRNA is further processed through cleavage by an RNase named Dicer to form a duplex intermediate resembling siRNA molecules. The miRNA is then transferred from the RNA duplex into an RNA-induced silencing complex (RISC), in which context it mediates sequence-specific gene silencing by either translational arrest or mRNA transcript cleavage.
Recent progress in transgene and RNAi expression cassettes CR Ill and HC Chiou with target sequences complementary to the miRNA sequence. 39 By substituting the sequences forming the stem of the pre-miRNA structure with a sequence complementary to a target gene, the specificity of the silencing mechanism can be redirected against any gene.
Though the sequence requirements for maturation of miRNAs are not yet fully defined, certain features are important and must be considered in designing premiRNA hairpins. The stem sequence itself, which encodes the mature miRNA, does not appear important for processing, and can be altered to target the chosen gene. Disruption of the base of the stem, however, significantly reduces miRNA expression. 40 Additionally, shortening of the terminal loop to four nucleotides or less, or placing too large a bulge in the middle of the stem, can negatively impact expression.
Given the more complex secondary structure of premiRNAs, de novo design of miRNA transcripts is difficult. The simplest approach thus far has been to insert sequences complementary to the target gene into the framework of a known, endogenous pre-miRNA. However, the effect on secondary structure of the replacement sequences is not always predictable, thus a significant amount of empirical trial and error is sometimes needed to identify a potent inhibitory sequence. Further advances in the in silico prediction of RNA secondary structure and in understanding the sequence and structural considerations important for miRNA biogenesis and maturation 41 will help to provide greater reliability and flexibility in the design of Pol II driven RNAi expression cassettes.
Prospects
The mining of databases linking sequence and functional information will play an increasingly significant role in optimization of mammalian expression cassette design. Future expression cassettes will be designed using programs that consider codon usage, codon pairing, CpG motifs and destabilizing elements such as ARE. Promoter selection for regulated gene therapy will be aided by databases where functional characterization is included. The expression cassette will consider the promoter activity in terms of strength and constitutive, environmental or the tissue-specific requirement for therapy. General sequence analyses in the future should also include determination of NCSS, which may result in aberrant splicing of cDNA, and potentially secondary structures for nuclease sensitive single-stranded regions in the expression cassette. Compilation of a growing amount of empirical data on effective sequences for RNAi continues to help improve predictive algorithms for the design of siRNA and shRNA molecules. As more data are obtained on miRNA biogenesis, processing and targets, algorithms will also become available for the design of Pol II-driven RNAi expression cassettes.
